DEVELOPMENT AND PROPERTIES OF NEUTRALIZING MONOCLONAL ANTIBODIES FOR FUSION PROTEIN OF RESPIRATORY SYNCYTIAL VIRUS

DEVELOPMENT AND PROPERTIES OF NEUTRALIZING MONOCLONAL ANTIBODIES FOR FUSION PROTEIN OF RESPIRATORY SYNCYTIAL VIRUS

Introduction. Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract infections in infants and the elderly. The absence of a wide range of therapeutic drugs and vaccines indicates to the high relevance of the development of new effective drugs for the prevention and tr...

Full description

Bibliographic Details
Main Authors:	A. A. Kushch, R. R. Klimova, N. E. Fedorova, O. V. Masalova, A. A. Niconova, E. I. Lesnova, E. D. Momotyuk, N. A. Demidova, T. G. Samartseva, V. V. Zverev
Format:	Article
Language:	English
Published:	Central Research Institute for Epidemiology 2019-04-01
Series:	Вопросы вирусологии
Subjects:	f-белок monoclonal antibodies respiratory syncytial virus reaction of biological neutralization immunoenzyme assay f-protein immunodot immunofluorescence and immunoperoxidase detection of rsv in infected cells
Online Access:	https://virusjour.crie.ru/jour/article/viewFile/238/141

Similar Items

GENETIC AND ANTIGENIC CHARACTERISTICS OF RESPIRATORY SYNCYTIAL VIRUS STRAINS ISOLATED IN ST. PETERSBURG IN 2013-2016
by: V. Z. Krivitskaya, et al.
Published: (2017-12-01)

Obtaining and Characterization of the Monoclonal Antibodies Against G-Protein of the Respiratory Syncytial Virus
by: N. A. Demidova, et al.
Published: (2020-04-01)

TEKNIK IMUNOHISTOKIMIA SEBAGAI PENDETEKSI ANTIGEN SPESIFIK PENYAKIT INFEKSI
by: Yani Rahayu, et al.
Published: (2015-09-01)

Comparative evaluation of immunoperoxidase versus immunofluorescent techniques in interpretation of kidney biopsies
by: Swasti Shubham, et al.
Published: (2016-01-01)

The comparison of hislopalhological, immunoperoxidase and immunofluorescence techniques in the diagnosis of rabies in dogs
by: Sevil (Atalay) Vural

Prophylaxis of respiratory syncytial virus infection: current status and prospects for vaccine development
by: A. S. Korovkin, et al.
Published: (2024-10-01)

Characteristics of the First Italian Older Adults Vaccinated with an Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine
by: Alexander Domnich, et al.
Published: (2025-01-01)

Evaluation of the performance of immunoblot and immunodot techniques used to identify autoantibodies in patients with autoimmune diseases
by: EL Hassouni Youssef, et al.
Published: (2021-03-01)

Anti-Idiotypic Antibody as a Booster Vaccine Against Respiratory Syncytial Virus
by: Shreya Mukhopadhyay, et al.
Published: (2025-01-01)

Molecular Mimicry between Respiratory Syncytial Virus F Antigen and the Human Proteome
by: Darja Kanduc
Published: (2023-01-01)

Direct Immunofluorescence and Immunohistochemistry in Diagnostics of Glomerulonephritis
by: Zinaida Karasalihović, et al.
Published: (2008-02-01)

Fc-mediated functions of nirsevimab complement direct respiratory syncytial virus neutralization but are not required for optimal prophylactic protection
by: Tyler Brady, et al.
Published: (2023-10-01)

Intranasal Vaccination with a Respiratory-Syncytial-Virus-Based Virus-like Particle Displaying the G Protein Conserved Region Induces Severe Weight Loss and Pathology upon Challenge with Wildtype Respiratory Syncytial Virus
by: Megolhubino Terhüja, et al.
Published: (2024-05-01)

Immunogenicity, safety and reactogenicity of Ad26.RSV.preF/RSV preF protein vaccine in adults aged 60 to 75 years: A comparison of phase 2b and phase 3 clinical trial material
by: Archana Jastorff, et al.
Published: (2024-12-01)

Immunohistochemical evaluation of akabane virus infection in aborted and new-born calves
by: M. Haligur, et al.
Published: (2014-05-01)

The RSV F p27 peptide: current knowledge, important questions
by: Wanderson Rezende, et al.
Published: (2023-06-01)

Cost-effectiveness Analysis of Maternal Immunization with RSVpreF Vaccine for the Prevention of Respiratory Syncytial Virus Among Infants in Spain
by: Javier Álvarez Aldean, et al.
Published: (2024-05-01)

Respiratory Syncytial Virus Matrix Protein Is Sufficient and Necessary to Remodel Host Mitochondria in Infection
by: MengJie Hu, et al.
Published: (2023-05-01)

Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication
by: Jackelyn Murray, et al.
Published: (2022-04-01)

Adherence to Palivizumab for Respiratory Syncytial Virus Prophylaxis in Romanian Infants
by: Andreea Calomfirescu-Avramescu, et al.
Published: (2025-02-01)

Epidemiology and molecular characteristics of respiratory syncytial virus (RSV) among italian community-dwelling adults, 2021/22 season
by: Donatella Panatto, et al.
Published: (2023-03-01)

Mutation of Respiratory Syncytial Virus G Protein’s CX3C Motif Attenuates Infection in Cotton Rats and Primary Human Airway Epithelial Cells
by: Binh Ha, et al.
Published: (2019-07-01)

Age-Stratified Seroprevalence of Respiratory Syncytial Virus: Analysis Using Prefusion F and G Protein Antibodies
by: Eliel Nham, et al.
Published: (2024-05-01)

A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults
by: Antonios O. Aliprantis, et al.
Published: (2021-05-01)

Exploring parental perspectives: Maternal RSV vaccination versus infant RSV monoclonal antibody
by: Bryony Treston, et al.
Published: (2024-12-01)

Genomic Evolution and Surveillance of Respiratory Syncytial Virus during the 2023–2024 Season
by: Madeline Yunker, et al.
Published: (2024-07-01)

CLINICAL AND IMMUNOLOGICAL CHANGES OF NON-GONOCOCCAL URETHRITIS
by: M.A. GADOEV, et al.
Published: (2020-03-01)

Epidemiology and clinical characteristics of hospitalized adults with respiratory syncytial virus infection at a medical center in northern Taiwan
by: Wen-Cheng Chang, et al.
Published: (2024-12-01)

Maternal Effects of Respiratory Syncytial Virus Infection during Pregnancy
by: Sarahn M. Wheeler, et al.
Published: (2015-11-01)

Development, Current Status, and Remaining Challenges for Respiratory Syncytial Virus Vaccines
by: Cleo Anastassopoulou, et al.
Published: (2025-01-01)

The Development of Animal Models for Respiratory Syncytial Virus (RSV) Infection and Enhanced RSV Disease
by: Gengxin Zhang, et al.
Published: (2024-10-01)

Epidemiology and molecular analyses of respiratory syncytial virus in the 2021–2022 season in northern Italy
by: Alessia Lai, et al.
Published: (2024-01-01)

The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis
by: Daisuke Kurai, et al.
Published: (2024-12-01)

Flexible RSV Prefusogenic Fusion Glycoprotein Exposes Multiple Neutralizing Epitopes that May Collectively Contribute to Protective Immunity
by: Nita Patel, et al.
Published: (2020-10-01)

Protective antigenic sites identified in respiratory syncytial virus fusion protein reveals importance of p27 domain
by: Jeehyun Lee, et al.
Published: (2021-11-01)

Enhancing Anti-G Antibody Induction by a Live Single-Cycle Prefusion F—Expressing RSV Vaccine Improves In Vitro and In Vivo Efficacy
by: Pramila Lamichhane, et al.
Published: (2022-11-01)

Economic and Clinical Benefits of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Prevention of RSV in Infants: A Cost-Effectiveness Analysis for Mexico
by: José Luis Huerta, et al.
Published: (2025-01-01)

Development and Validation of an Enzyme-Linked Immunosorbent Assay-Based Protocol for Evaluation of Respiratory Syncytial Virus Vaccines
by: Eliel Nham, et al.
Published: (2024-06-01)

Confronting the challenge: a regional perspective by the Latin American pediatric infectious diseases society (SLIPE) expert group on respiratory syncytial virus—tackling the burden of disease and implementing preventive solutions
by: Roberto Debbag, et al.
Published: (2024-07-01)

Role of bovine respiratory syncytial virus in etiology of respiratory diseases on milk farms
by: S. V. Koteneva, et al.
Published: (2021-03-01)